Skip Navigation LinksHome > April 2014 - Volume 26 - Issue 2 > Pediatric nephrolithiasis and the link to bone metabolism
Current Opinion in Pediatrics:
doi: 10.1097/MOP.0000000000000069
NEPHROLOGY: Edited by Michel Baum

Pediatric nephrolithiasis and the link to bone metabolism

Schwaderer, Andrew Lawrencea,b; Kusumi, Kirstena,c; Ayoob, Rose Marya

Collapse Box

Abstract

Purpose of review

To review the recent publications describing the link between pediatric nephrolithiasis and bone metabolism.

Recent findings

Nephrolithiasis incidence is increasing in children and is associated with low bone mineral density (BMD). Affected children are conceptually at risk for fractures and osteoporosis. In addition to abnormal calcium metabolism, inflammation, genetic makeup and dietary habits are being recognized as important factors in the pathophysiology of nephrolithiasis and low bone density. Findings from retrospective reviews suggest that low BMD in children may be improved with citrate or thiazide treatment.

Summary

The healthcare burden from low BMD with subsequent osteoporosis and fracture risk is immense with potential far-reaching effects in patient quality of life and healthcare expense. Bone mass is acquired in the pediatric age range, thus it is important to identify and treat at-risk children. Retrospective reviews in pediatric patients indicate that citrate or thiazide diuretic treatment may improve BMD. We now understand that a relationship exists between nephrolithiasis and low BMD. To improve healthcare for our current patients as well as protect their future health it is important to identify low BMD and initiate strategies to improve BMD in ‘at-risk’ children.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.